Screener
Climb Bio, Inc. CLYM Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $479K.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
FAQ
- What is Climb Bio, Inc.'s total debt?
- Climb Bio, Inc. (CLYM) reported total debt of $479K in Q1 2026.
- How has Climb Bio, Inc.'s total debt changed year-over-year?
- Climb Bio, Inc.'s total debt increased by 1.1% year-over-year, from $474K to $479K.
- What is the long-term trend for Climb Bio, Inc.'s total debt?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s total debt has grown at a -11.9% compound annual growth rate (CAGR), from $900K to $541K.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Climb Bio, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude